The neuropathological diagnosis of Alzheimer’s disease (AD) requires the presence of two core pathologies: extracellular beta amyloid (amyloid, Aβ) plaques and aggregated tau protein forming intra-neuronal neurofibrillary tangles (tau, NFT) [1,2]. The gene discussed is MAPT; the disease is Alzheimer disease.